Meropenem FDA Link Generic

A thienamycin derivative antibacterial agent that is more stable to renal dehydropeptidase I than IMIPENEM, but does not need to be given with an enzyme inhibitor such as CILASTATIN. It is used in the treatment of bacterial infections, including infections in immunocompromised patients.

Also Known As:

Merrem; 3- (5- Dimethylcarbamoylpyrrolidin- 3- ylthio)- 6- (1- hydroxyethyl)- 4- methyl- 7- oxo- 1- azabicyclo(3.2.0)hept- 2- ene- 2- carboxylic acid; Penem; Ronem; SM 7338; SM-7338; SM7338; 1- Azabicyclo(3.2.0)hept- 2- ene- 2- carboxylic acid, 3- ((5- ((dimethylamino)carbonyl)- 3- pyrrolidinyl)thio)- 6- (1- hydroxyethyl)- 4- methyl- 7- oxo- , (4R- (3(3S*,5S*),4alpha,5beta,6beta(R*)))-

Organic Chemicals: 133
- Amides: 2428
  - Lactams: 2198
    - beta-Lactams: 2386
      - Carbapenems: 4837
        Thienamycins: 1
        Meropenem: 2237
Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - beta-Lactams: 2386
      - Carbapenems: 4837
        Thienamycins: 1
        Meropenem: 2237

Akito Ishida Selected Research

Akito Ishida Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure